SCHEMBL14059397

SCHEMBL14059397

[CH2]C1=C(C)c2cc(Br)ccc2CCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PARP1 P09874 1/20 0.40
PARP10 Q53GL7 1/20 0.40
TYMS P04818 2/20 0.38
APP P05067 1/20 0.35
BACE1 P56817 1/20 0.35
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
S100A4 P26447 1/20 0.34
METAP1 P53582 1/20 0.34
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PNMT P11086 1/20 0.33
ASIC3 Q9UHC3 1/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14958183 0.76 TDP1 (0.41) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL14958358 0.76 TDP1 (0.41) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL14059227 0.74 TDP1 (0.43) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL30643139 0.74 METAP1 (0.46) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL6209711 0.74 METAP1 (0.46) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL14059697 0.72 METAP1 (0.57) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL14059228 0.71 SLC6A3 (0.40) TDP1L3MBTL1PARP1PARP10
SCHEMBL23264456 0.71 L3MBTL1 (0.62) TDP1L3MBTL1PARP1PARP10CCNB2
SCHEMBL9948229 0.71 PARP10 (0.44) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL29483386 0.71 MAOA (0.53) TDP1L3MBTL1PARP1PARP10TYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162330-A1 TRICYCLIC COMPOUNDS AS INHIBITORS FOR THE PRODUCTION OF BETA-AMYLOID BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-29 WO disclosed